Towards Healthcare
Serum Gonadotrophin API Market to Rise USD 202.93 Mn by 2034

Serum Gonadotrophin API Market Future Fueled by ART Growth

According to market projections, the serum gonadotrophin API sector is expected to grow from USD 131 million in 2024 to USD 202.93 million by 2034, reflecting a CAGR of 4.64%. The market is growing due to rising demand for fertility treatment and assisted reproductive technologies. Additionally, the increasing prevalence of infertility and the expanding application in animal breeding are driving market growth.

Content

  • Insight Code: 6112
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The serum gonadotrophin API market is valued at USD 137.1 million in 2025 and is on track to reach USD 202.93 million by 2034, witnessing a steady CAGR of 4.64% during the forecast span.

North America is currently leading the serum gonadotrophin API market due to growing demand for advanced fertility solutions and rising prevalence of age-related infertility.

The serum gonadotrophin API market includes 5 segments by product type, by source, by application, by end user, and by region.

Some key players include Merck KGaA, Ferring Pharmaceuticals, Sanofi Active Ingredients, Organon & Co., Sun Pharmaceutical Industries, and Teva API.

Key trends include the growth due to rising demand for fertility treatment and assisted reproductive technologies.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions